Search Results 731-740 of 16374 for pharmacogenetics
Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic studies PINK1/PRKN (Parkin)-directed mitochondrial quality control.
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
The purpose of this study is to access long-term quality of life, complications, and implications of treatments on patients who are long-term survivors of ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
About this study. Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to ...
The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...
Mayo Clinic offers many training opportunities for aspiring researchers.
To address this, Dr. Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.